CSDR – mandatory buy-ins COGESI meeting, November 26th 2014 Overview What is a buy-in? Problems executing buy-ins CSDR Mandatory buy-ins SFTs and partial exemption The likely impact of mandatory buy-ins Damage limitation: ICMA and industry recommendations Raising industry awareness and interaction with regulators Key take-aways CSDR is settlement regulation with major trading impacts, which is in itself a problem Mandatory buy-ins pose a significant threat to European bond market liquidity Mandatory buy-ins will discourage lending of securities and fragment the European repo market Mandatory buy-ins will most likely have the counterproductive impact of reducing settlement efficiency While it may no longer be possible to reverse the regulation, it is critical that users of the secondary bond and repo markets work with ESMA, the EC, the ECB, local regulatory authorities, local central banks, and DMOs to ensure that is implemented in a way that causes the least disruption and damage to market liquidity and efficiency What is a buy-in? A buy-in is a remedy available to the purchaser of a security in the event that the seller of the purchaser fails to make good delivery on intended settlement date. The failed-to purchaser (the ‘disappointed counterparty’) has the right to purchase the failing securities from another counterparty (normally executed by an appointed principal intermediary, known as the ‘buy-in agent’), for guaranteed delivery, to replace the original failing purchase. An differential in price between the original failing purchase and the buy-in is settled between the two counterparties. This ensures that both counterparties, from an economic perspective, are in the same position they would have been had the original trade settled as intended, In practice, the failing counterparty will often be disadvantaged since the buy-in will leave them with a long position that they will need to flatten in the market, at a market price that will, in almost all instances, be below the buy-in price. The less liquid the bond, the greater the buy-in price/market price differential is likely to be. Transactions under ICMA rules allow for a buy-in remedy. Buy-in flow diagram A’s sale to B fails A B B issues a buy-in against A A Price difference B Buy-in Agent Market Buy-in chains and ‘pass-ons’ A’s sale to B fails, causing a chain of fails A B C D D issues a buy-in against C, and the buy-in is passed along the chain back to A A Pass-on Px Difference B Pass-on Buy-in C D Px Difference Px Difference Market Buy-in Agent Problems with executing buy-ins Tend to be in less liquid bonds, which makes them more difficult to find Buy-in prices can often be very far from ‘fair market value’, creating market distortions A counterparty being bought-in has market risk until they flatten their position. If there is a delay in communicating that the buy-in has been executed this will expose them to unknown market risk Bought-in securities still may not settle It may be difficult to find buy-in agents Buy-ins can cause relationship issues Most investors understand that to get market pricing in, and market exposure to, illiquid securities, they may need to accept that securities will not settle on ISD CSDR Mandatory Buy-ins Regulation on improving securities settlement in the European Union and on central securities depositories (CSDR) aims to improve safety and efficiency of securities settlement in Europe Article 7, which deals with measures to prevent settlement fails (better known as ‘settlement discipline’), provides for: CSDs to establish systems to monitor fails CSDs to provide a penalty mechanism which will serve as a deterrent for settlement fails A mandatory buy-in process to be initiated where a transaction is still failing 4 days after intended settlement date (ISD) – this has scope to be increased to 7 days, depending on liquidity of the security being bought in Securities financing transactions (SFTs) to have a partial exemption from mandatory buy-ins Challenges of implementing mandatory buy-ins Buy-ins currently occur at the trading level. CSDR provides that this should occur at the settlement level. How can this disconnect be reconciled? Can CSDs differentiate between failing transaction types (important for exempt SFTs)? Can CSDs identify why a trade is failing (i.e. should there even be a buy-in)? Can CSDs identify fail-chains and know who should be bought-in to settle the chain? What happens with fail-chains across different CSDs (including those outside of EEA)? How and when are buy-ins communicated at the trading level (since this increases market risk)? Central clearing counterparties (CCPs) are exempt. How does this impact buy-in chains? What should be the calibration for the extension periods (4-7 days) for different securities (MiFID II?) What is the impact of exempting some SFTs and not all? SFTs and partial exemption ? CSDR Level 1 text suggests that some SFTs may be exempt from mandatory buy-ins “where the timeframe of these operations is sufficiently short and renders the buy-in ineffective”. This is interpreted as meaning near-legs of SFTs where the far-leg falls before the earliest practicable settlement date for a related buy-in. Thus the near-legs of short-dated repos would be exempt, but not the near-legs of term repos. The text is vague about whether far-legs should be exempt or not. Logically there is no reason to exempt far-legs, regardless of the duration of the SFT. But in the event that far-legs are exempt, a GMRA mini-close-out could still provide some risk mitigation in a mandatory buy-in regime. Current remedies for failing SFTs (under GMRA/GMSLA) The Global Master Repurchase Agreement, which is the standard legal framework for the European repo markets, and the Global Master Securities Lending Agreement (GMSLA), provide remedies for the disappointed counterparty in the event of a failed settlement. In the event of default (i.e. a fail), the contract allows for the disappointed counterparty to initiate a ‘mini-close-out’. This effectively closes the transaction. Where the fail is on the near-leg of a repo/loan, the disappointed counterparty can claim from the failing counterparty any interest that would have been accrued had the repo settled, up until the close-out date. Where the fail is on the far-leg of a repo/loan, the disappointed counterparty can claim from the failing counterparty any costs arising from replacing the securities. Economically, this is the equivalent of a buy-in. These remedies apply regardless of the term of the repo/loan, or the underlying security or asset type. Current remedies for failing repos: pros and cons Pros: Lenders (repo-ers) are not discouraged from lending, since they are not exposed to any unquantifiable buy-in risk. Given the economics of securities lending, this is critical to support market liquidity. Lenders (repo-ers) are protected in the event of a borrower (reverser) failing to return securities at the end of a repo, in which case they can issue the equivalent of a buy-in against the failing counterparty. A buy-in would be the wrong remedy for a failing repo start-leg, since the disappointed counterparty is only looking to borrow the security, not to buy it Cons: It is not possible to pass-on buy-ins in a fails chain that includes the near-leg of a repo. Market-makers who borrow (reverse) securities to facilitate sales are unable to hedge their buy-in exposure. However, in a market environment where buy-ins are infrequent, this risk is relatively low. It could, however, become significant under a mandatory buy-in regime. CSDR partial exemption: the worst of all scenarios Partial-exemption will fracture liquidity in SFTs, creating a two-tier market with different demand-supply skews: Lender of securities will only want to lend for short-dates (exempt) to avoid unquantifiable buy-in risk in the case of failing on their delivery of the near–leg of the trade Borrowers (such as market-makers) will have a preference to borrow securities for term (non-exempt) to hedge their buy-in risk If CSDs are responsible for initiating or managing buy-ins, they will need to be able to differentiate between SFTs and outright trades, near-legs and far-legs of SFTs, and the term of the SFT (exempt or non-exempt) Partial exemption: the worst of all scenarios (continued) Failing near-legs of exempt SFTs will still break any potential buy-in chain, leading to multiple buy-ins. Repo desks will face greater buy-in risk from managing term mismatches, which will deter their liquidity provision to the market. CCPs may need to separate exempt and non-exempt SFTs for different netting treatments. Dealers and other market participants will need to manage exempt transactions (short-dated SFTs) separately from non-exempt transactions (cash trades and term-SFTs). o NB: it is assumed that far-legs of all SFTs (regardless of term) would be in scope, but this is not clear from the text. If the intention is to partially exempt the far-legs of some SFTs, this will cause even more complexity and asymmetry. Term structure of the European repo markets 25% 20% 15% repo reverse repo 10% 5% 0% Source: ICMA-ERC Repo Survey June 2014 What will be the likely impact of mandatory buy-ins Increased risk and cost to market-makers, who will either only show offers in securities they hold, or will widen spreads to reflect risk Increased administrative and legal stress, as well as market risk, as number of buy-ins to manage increases exponentially Market disruption caused by multiple buy-ins, particularly in less liquid securities Reduced lending of securities where SFTs are in scope of buy-ins A reduction in settlement efficiency and increased fails as lending pool of securities reduces Ever more buy-ins as an unvirtuous circle of settlement inefficiency takes hold Damage limitation: ICMA and industry recommendations There are already initiatives in place to improve settlement efficiency in Europe (Target2-Securities, ICSD ‘bridge’ enhancement, COGESI workstreams, etc.): these should be successfully implemented first A well designed cash penalty/compensation scheme could improve settlement efficiency would have a less disruptive impact than buy-ins Buy-in should be executed at the trading level, not the settlement level Buy-in chains should be initiated at the end of the chain (last counterparty being failed to), and the buy-in passed along to the initial failing counterparty CCPs should be included in buy-in chains Extension periods (4-7 days) should be consistent with liquidity calibrations of MiFID II The near-legs of SFTs, as much as possible, should be out of scope of mandatory buy-ins (with a minimum 3mth term cut-off for exemption) A solution looking for a problem Bond Market Settlement Efficiency 100.0% 98.0% 96.0% 94.0% 92.0% 90.0% 88.0% 86.0% 84.0% 82.0% ISD+0 ISD+1 ISD+2 ISD+3 ISD+4 ISD+5 EM Source: ICMA-ERC Settlement Efficiency survey, 2014 Gvt ISD+6 Corp ISD+7 ISD+8 ISD+9 ISD+10 Later A solution looking for a problem Repo Market Settlement Efficiency 100.0% 98.0% 96.0% 94.0% 92.0% 90.0% 88.0% 86.0% 84.0% ISD+0 ISD+1 ISD+2 ISD+3 ISD+4 ISD+5 EM Source: ICMA-ERC Settlement Efficiency survey, 2014 Gvt ISD+6 Corp ISD+7 ISD+8 ISD+9 ISD+10 Later Raising industry awareness and interaction with regulators To date: CSDR CP and DP consultation (May 2014) ERC discussion and position paper (June 2014) AFME workshop and ICMA hosted industry meetings (June/July 2014) 2-day ICMA-AFME industry workshop to prepare for ESMA roundtable (September 2014) ESMA industry roundtable on settlement discipline (September 2014) ESMA meeting with ICMA and ISLA on mandatory buy-ins and SFTs (September 2014) Ongoing: Continue to raise awareness of negative impact of mandatory buy-ins among market participants and national regulatory bodies ESMA consultation on settlement discipline expected later in 2014
© Copyright 2026 Paperzz